EMA Authorised: Celsentri (maraviroc) — ViiV Healthcare B.V.

View source ↗

Summary

The European Medicines Agency authorised Celsentri (maraviroc) for HIV infections, with ViiV Healthcare B.V. as the marketing authorization holder, on 20 Novemb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Celsentri (maraviroc)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: ViiV Healthcare B.V.. Decision date: 20/11/2025